30 mCi Radioiodine Treatment of Thyroid Carcinoma Patients in the post ESTIMABL Era

被引：0
|
作者：
Rusu, D. [1 ]
Fleury, V. [1 ]
Palpacuer, C. [2 ]
Le Thiec, M. [1 ]
Colombie, M. [1 ]
Kraeber-Bodere, F. [1 ,3 ,4 ]
Rousseau, C. [1 ,4 ]
机构：
[1] ICO Canc Fighting Ctr, Nucl Med, St Herblain, France
[2] ICO Canc Fighting Ctr, Stat Unit, St Herblain, France
[3] Univ Hosp, Nucl Med, Nantes, France
[4] CNRS, INSERM, CRCNA, U892,UMR 6299, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-568
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [31] Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma
    Rossi, Mattia
    Mele, Chiara
    Rossetto Giaccherino, Ruth
    Meomartino, Letizia
    Brero, Denise
    Marsan, Giulia
    Aimaretti, Gianluca
    Ghigo, Ezio
    Pagano, Loredana
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [32] Non-inferiority of 30 versus 100 mCi of 131-I in post-surgical ablation in patients with differentiated thyroid carcinoma
    Markovic, V.
    Punda, A.
    Eterovic, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S276 - S276
  • [33] Can histopathological factors predict the outcome of radioiodine treatment in patients with differentiated thyroid carcinoma?
    Gao, Zairong
    Chang, Wei
    Zhang, Yongxue
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [34] The effect of radioiodine treatment on the development of second primary cancer in patients with differentiated thyroid carcinoma
    Fallahi, B.
    Beiki, D.
    Fard-Esfahani, A.
    Haghpanah, V.
    Eftekhari, M.
    Emami-Ardekani, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S319 - S319
  • [35] Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone
    Paz-Filho, G. J.
    Mesa, C. O., Jr.
    Olandoski, M.
    Woellner, L. C.
    Goedert, C. A.
    Boguszewski, C. L.
    Carvalho, G. A.
    Graf, H.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (12) : 1661 - 1670
  • [36] VALUE OF RADIOIODINE THERAPY IN THE TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA
    SCHUMICHEN, C
    SCHEUFFELEN, C
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P112 - P112
  • [37] Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma
    Balenovic, Antonija
    Vlasic, Marko
    Sonicki, Zdenko
    Bodor, Davor
    Kusic, Zvonko
    COLLEGIUM ANTROPOLOGICUM, 2006, 30 (04) : 743 - 748
  • [38] Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma
    Van Nostrand, D
    Atkins, F
    Yeganeh, F
    Acio, E
    Bursaw, R
    Wartofsky, L
    THYROID, 2002, 12 (02) : 121 - 134
  • [39] Thyroid Carcinoma Metastasis to Skull with Infringement of Brain: Treatment with Radioiodine
    Sisson, James C.
    Dewaraja, Yuni K.
    Wizauer, Eric J.
    Giordano, Thomas J.
    Avram, Anca M.
    THYROID, 2009, 19 (03) : 297 - 303
  • [40] HEMATOLOGICAL EFFECTS FROM RADIOIODINE TREATMENT OF THYROID-CARCINOMA
    KELDSEN, N
    MORTENSEN, BT
    HANSEN, HS
    ACTA ONCOLOGICA, 1990, 29 (08) : 1035 - 1039
12345